You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

American Society for Microbiology

Overview
In The News
Executives & Employees
Board of Directors
Paths
Non-Profit Donations & Grants Received
Suppliers

American Society for Microbiology

Overview

Date Founded
1899
Headquarters
1752 N Street Nw Washington Dc 20036-2904
Employees (Worldwide)
191
Company Description
TO PROMOTE AND ADVANCE THE MICROBIAL SCIENCES.
Website

In The News See More

PR Newswire
June 7, 2017
Marketline Newswire
June 5, 2017
GlobeNewswire
June 5, 2017
GlobeNewswire
June 5, 2017
Business Wire
June 5, 2017
See full news coverage and complete stories with RelSci Professional.

Executives & Employees See More


President

Executive Director

Interim Executive Director

Director, Information Systems

Director, International Affairs

Director, Meetings & Exhibits

Director, Public Affairs

Director, Human Resources & Administration

Treasurer

Secretary
See our list of current and previous employees when you upgrade.

Board of Directors


Co-Founder at PMV Pharmaceuticals, Inc.

Member, Scientific Review Board at Howard Hughes Medical Institute, Inc.

Director at American Society for Microbiology

Director at American Society for Microbiology

Director at American Society for Microbiology

Director at American Society for Microbiology

Director at American Society for Microbiology

Director at American Society for Microbiology

Director at American Society for Microbiology

Director at American Society for Microbiology
See our list of current and previous board members when you upgrade.

Paths to American Society for Microbiology

American Society for Microbiology
You
Connections via Relationship Science
American Society for Microbiology
Sync your contacts to see how you can connect with American Society for Microbiology.

Non-Profit Donations & Grants Received

$81.9K
The Alfred P. Sloan Foundation believes that a carefully reasoned and systematic understanding of the forces of nature and society, when applied inventively and wisely, can lead to a better world for all. The Foundation makes grants to support original research and broad-based education related to science, technology, and economic performance; and to improve the quality of American life. Though founded in 1934 by Alfred P. Sloan Jr., then-President and CEO of General Motors, the Foundation is an independent entity and has no formal relationship with the General Motors Corporation. The Foundation is unique in its focus on science, technology, and economic institutions. It believes the scholars and practitioners who work in these fields are chief drivers of the nation’s health and prosperity. In each grant program, the Foundation seeks proposals for original projects led by outstanding individuals or teams. The Alfred P. Sloan Foundation is interested in projects that it expects will result in a strong benefit to society, and for which funding from the private sector, the government, or other foundations is not widely available.
$13
Over the last five years, the Pfizer Foundation and Pfizer Worldwide Philanthropy department has developed platform focused on investing the full range of the company's resources — people, skills, expertise and funding — to broaden access to medicines and strengthen healthcare delivery for underserved people around the world. The new philanthropy platform, Pfizer Investments in Health, offers a more coordinated approach to contribute to society beyond medicines, centered around developing stronger relationships with their partners (grantees, field experts, etc.) and including cash grants, capacity building/technical assistance, product, skilled volunteers and stronger networking. This has resulted in mutual benefits for Pfizer and for its philanthropic partners. Introduction The Pfizer Foundation, the philanthropic arm of the world-leading pharmaceutical company, Pfizer Inc, is committed to addressing global health needs through community programs that also leverage its corporate resources and connections. Pfizer had successfully implemented international and smaller scale domestic HIV/AIDS programs, but recognized the need for greater national attention. In 2002, the Pfizer Foundation developed the Southern HIV/AIDS Prevention Initiative (SHAPI) in reaction to the growing HIV/AIDS epidemic in the southern United States. HIV/AIDS rates were still alarmingly high and growing, especially in the U.S. South. SHAPI, a three-year program from 2003 to 2006, provided more than $3 million in program investments and $3 million in capacity-building opportunities. To further develop the program and assist in its strategic planning and implementation the Foundation engaged TCC Group in 2002. Developing Focus and Goals In response to TCC Group's research and facilitated discussions with stakeholders, the Pfizer Foundation focused SHAPI on prevention programs in small to mid-size AIDS Service Organizations (ASOs), particularly those working with minorities and women. With TCC's help, the Foundation developed a clear set of goals for SHAPI. The core strategy focused on building relationships and supporting a targeted number of organizations, and included investments focused on direct services in local prevention and education programs and additional investments designed to create longer lasting impact through organizational capacity building and regional networking opportunities. Together, TCC and the Pfizer Foundation selected 23 grantees and 39 additional finalists. Grantees were provided annual grants of up to $50,000 for prevention programs, and all grantees and finalists were provided with opportunities to improve organizational effectiveness and be a part of the SHAPI network. TCC managed the overall initiative and worked closely with grantees to achieve the SHAPI goals of capacity building and networking. Opportunities Beyond the Grants In order to offer grantees tailored capacity building opportunities, TCC Group developed a new, comprehensive assessment tool for nonprofit organizations that was based on best practices in the field and tested by leading ASOs (now further developed, available on-line and called the Core Capacity Assessment Tool (CCAT)). Using the CCAT, TCC identified target areas for capacity building in each participating organization as well as cross-cutting needs for clusters of organizations. Each SHAPI grantee was offered annual customized capacity building recommendations and funding support (which often was nearly equal to their program grant) as well as general opportunities, such as board development, peer mentoring, software and technology training, financial management, and evaluation technical assistance. In addition, TCC worked with the Foundation to provide networking opportunities to the SHAPI grantees and finalists, such as training sessions, teleconferences, and peer exchange. In particular, the Pfizer Foundation sponsored its SHAPI partners to attend the annual United States Conference on AIDS and hosted its own annual HIV/AIDS prevention conferences focused on HIV/AIDS prevention and capacity building needs identified throughout the year. During these networking opportunities, the Pfizer Foundation invited and introduced Pfizer Inc's HIV Community Liaisons (HCLs) to SHAPI partners to be able to foster more localized relationships with Pfizer Inc and to provide access to Pfizer Inc's local resources, such as training materials, mini-grants/sponsorships and volunteers. Through these networking opportunities, grantees and finalists shared ideas, information, and inspiration. "Long after Pfizer's funding relationship with [us] has concluded, the skills and expertise culled from these capacity-building efforts will continue to make [us] a trusted and well-respected organization." – NC Grantee
$64.9K
The Richard Lounsbery Foundation aims to enhance national strengths in science and technology through support of programs in the following areas: science and technology components of key US policy issues; elementary and secondary science and math education; historical studies and contemporary assessments of key trends in the physical and biomedical sciences; and start-up assistance for establishing the infrastructure of research projects. Among international initiatives, the Foundation has a long-standing priority in Franco-American scientific cooperation. The Foundation generally provides seed money or partial support, rarely renews grants for continuing activities, does not normally fund endowments or laboratory research, and aims to achieve high impact by funding novel projects and forward-looking leaders.
$50K
Bill & Melinda Gates Foundation work with partner organizations worldwide to tackle critical problems in four program areas. The Global Development Division works to help the world’s poorest people lift themselves out of hunger and poverty. The Global Health Division aims to harness advances in science and technology to save lives in developing countries. The United States Division works to improve U.S. high school and postsecondary education and support vulnerable children and families in Washington State. And the Global Policy & Advocacy Division seeks to build strategic relationships and promote policies that will help advance our work. The approach to grantmaking in all four areas emphasizes collaboration, innovation, risk-taking, and, most importantly, results.

Suppliers

   Consumer Services    Dallas, TX
Freeman Audio Visual Inc. provides a range of audio visual solutions and presentation technology services. The company is headquartered in Dallas, TX.
   Holding Companies    Chicago, IL
Coe-Truman Technologies, Inc. provides software products and services to the scientific and medical industries. It is a global entity designed to increase opportunities for medical, scientific, technical and professional societies to access leading edge workflow technology for meetings. The company was founded by Mark W. Coe in 1982 and is headquartered in Chicago, IL.
       STANFORD, CA

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.